SCHEMBL22889193

SCHEMBL22889193

c1ccc(-c2cccc3ccccc23)c(-c2nc(-c3c(-c4cccc5ccccc45)ccc4ccccc34)nc(-c3cccc4c3sc3ccccc34)n2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 1/20 0.40
ALOX5 P09917 1/20 0.39
PARP14 Q460N5 1/20 0.37
PRKDC P78527 6/20 0.34
PIK3CD O00329 2/20 0.34
PIK3CB P42338 2/20 0.34
MAPT P10636 4/20 0.33
GPR3 P46089 1/20 0.33
NQO1 P15559 1/20 0.32
NQO2 P16083 1/20 0.32
ALDH1A1 P00352 3/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
MEN1 O00255 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
ANPEP P15144 1/20 0.31
ATM Q13315 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
KDM4E B2RXH2 2/20 0.31
TP53 P04637 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25049947 0.97 ALOX5 (0.41) DNMT1ALOX5PARP14PRKDCPIK3CD
SCHEMBL21304431 0.97 ALOX5 (0.41) DNMT1ALOX5PARP14PRKDCPIK3CD
SCHEMBL21304467 0.96 ALOX5 (0.40) DNMT1ALOX5PARP14PRKDCPIK3CD
SCHEMBL22888813 0.93 ALOX5 (0.38) DNMT1ALOX5PARP14PRKDCPIK3CD
SCHEMBL21304703 0.93 ALOX5 (0.38) DNMT1ALOX5PARP14PRKDCPIK3CD
SCHEMBL22889063 0.93 ALOX5 (0.39) DNMT1ALOX5PARP14PRKDCPIK3CD
SCHEMBL22888853 0.93 ALOX5 (0.39) DNMT1ALOX5PARP14PRKDCPIK3CD
SCHEMBL22889325 0.91 ALOX5 (0.40) DNMT1ALOX5PARP14PRKDCPIK3CD
SCHEMBL25050228 0.91 ALOX5 (0.46) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL22888852 0.91 ALOX5 (0.46) ALOX5PARP14PRKDCPIK3CDPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR DNMT1 3236/4885ALOX5 3163/4885PARP14 346/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 DNMT1 3512/4885ALOX5 3071/4885PARP14 318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.